GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SMO Clinplus Co Ltd (SZSE:301257) » Definitions » Total Equity

SMO Clinplus Co (SZSE:301257) Total Equity : ¥1,106.2 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is SMO Clinplus Co Total Equity?

SMO Clinplus Co's total equity for the quarter that ended in Mar. 2024 was ¥1,106.2 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

SMO Clinplus Co Total Equity Historical Data

The historical data trend for SMO Clinplus Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMO Clinplus Co Total Equity Chart

SMO Clinplus Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial 125.19 164.96 228.84 951.97 1,080.60

SMO Clinplus Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 981.01 998.12 1,041.28 1,080.60 1,106.22

SMO Clinplus Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

SMO Clinplus Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=1366.819-286.224
=1,080.6

SMO Clinplus Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=1371.069-264.852
=1,106.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SMO Clinplus Co Total Equity Related Terms

Thank you for viewing the detailed overview of SMO Clinplus Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

SMO Clinplus Co (SZSE:301257) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SMO Clinplus Co Ltd (SZSE:301257) » Definitions » Total Equity
Comparable Companies
SHSE:688468 SZSE:300439 SHSE:603122 SZSE:301060 SZSE:300639 SHSE:603716 SHSE:688193 SZSE:300396 SZSE:300685 SZSE:300463 TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH
Traded in Other Exchanges
N/A
Address
No. 105 Sinan Road, Room 108, Building 1, Huangpu District, Shanghai, CHN, 200001
Website
http://www.smo-clinplus.com
SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.
Executives
Lai Chun Bao Director
Ma Lin Director

SMO Clinplus Co (SZSE:301257) Headlines

No Headlines